Caixin App
Newsletter
Go
Sections
Sections
Finance
Business & Tech
Economy
Environment
Politics & Law
Society & Culture
World
Editorial
Opinion
Blog
Video
Topics
Trouble at TikTok
Coronavirus
Fraud at Luckin
Coronavirus
Hobbled Huawei
China-U.S. Trade War
Digital Currency
Fintech / Internet Finance
Selected
China Business Digest
CX Daily
Tech Talk
Economic Indexes
Caixin Explains
CX Tech
Podcast
Video
Coronavirus
Newsletter
Events
中文
SUBSCRIBE
Clear
GO
Sort by:
Newest
Newest
Relevance
Oldest
Type:
All
All
News
CX Tech
Videos
Podcast
Gallery
In-Depth
Time:
Any Time
Any time
Past 24 Hours
Past Week
Past Month
Past Year
Custom Range
Range:
All
All
Headline
Byline
Full Text
Reset
Showing search results for
cui xiaotian
Prices of Legacy GSK Antibiotic Surge 50-Fold in China After Rumored Supply Halt
China Indicts Former AstraZeneca Executive on Fraud and Smuggling Charges
Tasly’s U.S. Drug Push Falters as Partner Ends Development Deal
In Depth: China’s Tech Giants Burn Cash to Try to Dominate AI Health Care
AstraZeneca Doubles Down on China With 100 Billion Yuan Pledge
AstraZeneca Doubles Down on China With 100 Billion Yuan Pledge
Analysis: New Safety Rules Unlikely to Trigger Mass Delistings of Chinese Traditional Medicines
AbbVie Bets Big on Chinese Cancer Drug in $5.6 Billion Licensing Deal
In Depth: The Battle to Make Cancer’s ‘Living Drug’ Affordable
Cover Story: Chinese Medicine Injections Face Rigorous Regulation for the First Time
Load more
Sign In
Sign In
Cancel
Remember me
Forgot Password
OR
Sign in with Google
Sign in with Facebook
Sign in with 财新通